These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
264 related items for PubMed ID: 21898754
1. Effects of a combination of oral anti-diabetes drugs with basal insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes. Mu PW, Chen YM, Lu HY, Wen XQ, Zhang YH, Xie RY, Shu J, Wang MM, Zeng LY. Diabetes Metab Res Rev; 2012 Mar; 28(3):236-40. PubMed ID: 21898754 [Abstract] [Full Text] [Related]
2. Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients. Derosa G, Maffioli P, Salvadeo SA, Ferrari I, Ragonesi PD, Querci F, Franzetti IG, Gadaleta G, Ciccarelli L, Piccinni MN, D'Angelo A, Cicero AF. Metabolism; 2010 Jun; 59(6):887-95. PubMed ID: 20015525 [Abstract] [Full Text] [Related]
3. Exenatide plus metformin compared with metformin alone on β-cell function in patients with Type 2 diabetes. Derosa G, Franzetti IG, Querci F, Carbone A, Ciccarelli L, Piccinni MN, Fogari E, Maffioli P. Diabet Med; 2012 Dec; 29(12):1515-23. PubMed ID: 22540883 [Abstract] [Full Text] [Related]
5. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin. Hermansen K, Kipnes M, Luo E, Fanurik D, Khatami H, Stein P, Sitagliptin Study 035 Group. Diabetes Obes Metab; 2007 Sep; 9(5):733-45. PubMed ID: 17593236 [Abstract] [Full Text] [Related]
7. Improved glycaemic control with BIAsp 30 in insulin-naïve type 2 diabetes patients inadequately controlled on oral antidiabetics: subgroup analysis from the IMPROVE study. Wenying Y, Benroubi M, Borzi V, Gumprecht J, Kawamori R, Shaban J, Shah S, Shestakova M, Ligthelm R, Valensi P, IMPROVE Study Group Expert Panel. Curr Med Res Opin; 2009 Nov; 25(11):2643-54. PubMed ID: 19751116 [Abstract] [Full Text] [Related]
8. Limitations of the HOMA-B score for assessment of beta-cell functionality in interventional trials-results from the PIOglim study. Pfützner A, Derwahl M, Jacob S, Hohberg C, Blümner E, Lehmann U, Fuchs W, Forst T. Diabetes Technol Ther; 2010 Aug; 12(8):599-604. PubMed ID: 20615100 [Abstract] [Full Text] [Related]
11. Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus. Kim HJ, Kang ES, Kim DJ, Kim SH, Ahn CW, Cha BS, Nam M, Chung CH, Lee KW, Nam CM, Lee HC. Clin Endocrinol (Oxf); 2007 Feb; 66(2):282-9. PubMed ID: 17224000 [Abstract] [Full Text] [Related]
17. Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: experience from the PRESENT study. Khutsoane D, Sharma SK, Almustafa M, Jang HC, Azar ST, Danciulescu R, Shestakova M, Ayad NM, Guler S, Bech OM, PRESENT Study Group. Diabetes Obes Metab; 2008 Mar; 10(3):212-22. PubMed ID: 18269636 [Abstract] [Full Text] [Related]